164 related articles for article (PubMed ID: 16361981)
1. Testotoxicosis: current viewpoint.
Reiter EO; Norjavaara E
Pediatr Endocrinol Rev; 2005 Dec; 3(2):77-86. PubMed ID: 16361981
[TBL] [Abstract][Full Text] [Related]
2. Treatment of familial male-limited precocious puberty with bicalutamide and anastrozole.
Kreher NC; Pescovitz OH; Delameter P; Tiulpakov A; Hochberg Z
J Pediatr; 2006 Sep; 149(3):416-20. PubMed ID: 16939760
[TBL] [Abstract][Full Text] [Related]
3. Treatment of familial male-limited precocious puberty (testotoxicosis) with anastrozole and bicalutamide in a boy with a novel mutation in the luteinizing hormone receptor.
Mitre N; Lteif A
J Pediatr Endocrinol Metab; 2009 Dec; 22(12):1163-7. PubMed ID: 20333877
[TBL] [Abstract][Full Text] [Related]
4. Bicalutamide and third-generation aromatase inhibitors in testotoxicosis.
Lenz AM; Shulman D; Eugster EA; Rahhal S; Fuqua JS; Pescovitz OH; Lewis KA
Pediatrics; 2010 Sep; 126(3):e728-33. PubMed ID: 20713483
[TBL] [Abstract][Full Text] [Related]
5. Testotoxicosis: Report of Two Cases, One with a Novel Mutation in LHCGR Gene.
Özcabı B; Tahmiscioğlu Bucak F; Ceylaner S; Özcan R; Büyükünal C; Ercan O; Tüysüz B; Evliyaoğlu O
J Clin Res Pediatr Endocrinol; 2015 Sep; 7(3):242-8. PubMed ID: 26831561
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of anastrozole and cyproterone acetate in two brothers with familial male precocious puberty.
Eyssette-Guerreau S; Pinto G; Sultan A; Le Merrer M; Sultan C; Polak M
J Pediatr Endocrinol Metab; 2008 Oct; 21(10):995-1002. PubMed ID: 19209621
[TBL] [Abstract][Full Text] [Related]
7. Long-term treatment of familial male-limited precocious puberty (testotoxicosis) with cyproterone acetate or ketoconazole.
Almeida MQ; Brito VN; Lins TS; Guerra-Junior G; de Castro M; Antonini SR; Arnhold IJ; Mendonca BB; Latronico AC
Clin Endocrinol (Oxf); 2008 Jul; 69(1):93-8. PubMed ID: 18088394
[TBL] [Abstract][Full Text] [Related]
8. Effect of Antiandrogen, Aromatase Inhibitor, and Gonadotropin-releasing Hormone Analog on Adult Height in Familial Male Precocious Puberty.
Leschek EW; Flor AC; Bryant JC; Jones JV; Barnes KM; Cutler GB
J Pediatr; 2017 Nov; 190():229-235. PubMed ID: 29144249
[TBL] [Abstract][Full Text] [Related]
9. [Testotoxicosis].
Fuse H; Akashi T; Watanabe A
Nihon Rinsho; 2006 Jun; Suppl 2():628-31. PubMed ID: 16817479
[No Abstract] [Full Text] [Related]
10. Combined treatment with bicalutamide and anastrozole in a young boy with peripheral precocious puberty due to McCune-Albright Syndrome.
Tessaris D; Matarazzo P; Mussa A; Tuli G; Verna F; Fiore L; Lala R
Endocr J; 2012; 59(2):111-7. PubMed ID: 22068112
[TBL] [Abstract][Full Text] [Related]
11. Effective aromatase inhibition by anastrozole in a patient with gonadotropin-independent precocious puberty in McCune-Albright syndrome.
Roth C; Freiberg C; Zappel H; Albers N
J Pediatr Endocrinol Metab; 2002; 15 Suppl 3():945-8. PubMed ID: 12199354
[TBL] [Abstract][Full Text] [Related]
12. Treatment of familial male precocious puberty with spironolactone and testolactone.
Laue L; Kenigsberg D; Pescovitz OH; Hench KD; Barnes KM; Loriaux DL; Cutler GB
N Engl J Med; 1989 Feb; 320(8):496-502. PubMed ID: 2492636
[TBL] [Abstract][Full Text] [Related]
13. Reply; Testotoxicosis: Report of Two Cases, One with a Novel Mutation in LHCGR Gene.
Evliyaoğlu O
J Clin Res Pediatr Endocrinol; 2016 Mar; 8(1):107. PubMed ID: 26757946
[No Abstract] [Full Text] [Related]
14. Preclinical diagnosis of testotoxicosis in a boy with an activating mutation of the luteinizing hormone receptor.
Teles M; Brito VN; Arnhold IJ; Mendonca BB; Latronico AC
J Pediatr Endocrinol Metab; 2006 Apr; 19(4):541-4. PubMed ID: 16759041
[TBL] [Abstract][Full Text] [Related]
15. Bicalutamide plus anastrozole for the treatment of gonadotropin-independent precocious puberty in boys with testotoxicosis: a phase II, open-label pilot study (BATT).
Reiter EO; Mauras N; McCormick K; Kulshreshtha B; Amrhein J; De Luca F; O'Brien S; Armstrong J; Melezinkova H
J Pediatr Endocrinol Metab; 2010 Oct; 23(10):999-1009. PubMed ID: 21158211
[TBL] [Abstract][Full Text] [Related]
16. Gonadotropin-independent precocious puberty.
Holland FJ
Endocrinol Metab Clin North Am; 1991 Mar; 20(1):191-210. PubMed ID: 1903104
[TBL] [Abstract][Full Text] [Related]
17. Strategies for maximizing growth in puberty in children with short stature.
Mauras N
Endocrinol Metab Clin North Am; 2009 Sep; 38(3):613-24. PubMed ID: 19717007
[TBL] [Abstract][Full Text] [Related]
18. Treatment with the aromatase inhibitor letrozole during adolescence increases near-final height in boys with constitutional delay of puberty.
Hero M; Wickman S; Dunkel L
Clin Endocrinol (Oxf); 2006 May; 64(5):510-3. PubMed ID: 16649968
[TBL] [Abstract][Full Text] [Related]
19. [The use of aromatase inhibitors in children].
Eyal O; Naugolny L; Weintrob N
Harefuah; 2009 Dec; 148(12):825-30, 855. PubMed ID: 20088436
[TBL] [Abstract][Full Text] [Related]
20. A Case of Familial Male-limited Precocious Puberty with a Novel Mutation.
Gurnurkar S; DiLillo E; Carakushansky M
J Clin Res Pediatr Endocrinol; 2021 Jun; 13(2):239-244. PubMed ID: 32757547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
